In addition, complement mediated injury has been documented in the lungs and skin of patients with severe COVID-19 with significant deposition of MASP-2, MBL and even ficolin-3 (21, 40), and MASP-2 deficient mice were protected from severe disease (22). Here, FCN3 is linked to COVID-19.